← FDA Drug Approvals (Drugs@FDA)

LORATADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PERRIGO PHARMA INTL · Approved 2019-06-12

Drug application

FDA Application #

ANDA210033

Application type

Abbreviated New Drug Application (Generic)

Brand name

LORATADINE

Generic name

LORATADINE

Active ingredients

LORATADINE

Dosage form

TABLET, CHEWABLE

Route

ORAL

Marketing status

Over-the-counter

Sponsor

PERRIGO PHARMA INTL

Manufacturer

H E B

First approval

2019-06-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown